Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a syndrome that resembles to heparin-induced thrombocytopenia (HIT). Platelet factor 4 (PF-4) reacts to a vaccine component resulting formation of immune complex that stimulates an autoimmune reaction triggering platelet consumption causin...

Full description

Bibliographic Details
Main Authors: Fernando García-Boyano, Clara M. Castro Ávila, Miguel Arguello-Tomás, Álvaro Moreno Cuervo, José Manuel Ligero Ramos, Cristina Pascual-Izquierdo
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Annals of Vascular Surgery - Brief Reports and Innovations
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772687822000642
Description
Summary:Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a syndrome that resembles to heparin-induced thrombocytopenia (HIT). Platelet factor 4 (PF-4) reacts to a vaccine component resulting formation of immune complex that stimulates an autoimmune reaction triggering platelet consumption causing thrombus formation and producing thrombotic events. When suspected is important to confirm for make a correct anticoagulation management to avoid complications related to unfractioned and low weight heparins use.In this report we describe a case of acute limb ischemia secondary to ChAdOx1 nCoV-19 vaccine (Astrazeneca, Cambridge, UK)
ISSN:2772-6878